NEKTAR THERAPEUTICS — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/92e5dc10-b6e1-4d65-8c52-44e11aaa2a93/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $55.2M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-104547 |
| FY 2024 | $98.4M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-039389 |
| FY 2023 | $90.1M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-026249 |
| FY 2022 | $92.1M | 2022-01-01 – 2022-12-31 | evidence 0000906709-23-000004 |
| FY 2021 | $101.9M | 2021-01-01 – 2021-12-31 | evidence 0000906709-22-000005 |
| FY 2020 | $152.9M | 2020-01-01 – 2020-12-31 | evidence 0000906709-21-000005 |
| FY 2019 | $114.6M | 2019-01-01 – 2019-12-31 | evidence 0000906709-20-000004 |
| FY 2018 | $1.2B | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005639 |
| FY 2017 | $307.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004105 |
| FY 2016 | $165.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-005639 |
| FY 2015 | $230.8M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013759 |
| FY 2014 | $200.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-063338 |
| FY 2013 | $44.8M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-073093 |
| FY 2012 | $35.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-085500 |
| FY 2011 | $24.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-089389 |
| FY 2010 | $159.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-089389 |
| FY 2009 | $30.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-089389 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NEKTAR THERAPEUTICS — all facts · Net Income · Operating Income